Bipolar disorder trials in Russia
1 trial · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
- Where
- Krasnodar, Moscow, Nizhny Novgorod, Orenburg, Saint Petersburg, Saratov, Stavropol
- Age
- 10 years to 17 years
- People
- 380 worldwide
- Run by
- AbbVie
See details and how to joinNCT04777357